Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 106, pseudogene (RN7SL106P)

Target: RN7SL106P
Molecular classification: Other, Pseudogene, non-coding RNA

Overview

RN7SL106P (RNA, 7SL, cytoplasmic 106, pseudogene) is classified as a pseudogene related to the 7SL RNA family. The 7SL RNA is normally a component of the signal recognition particle (SRP) complex, a ribonucleoprotein involved in targeting secretory and membrane proteins to the endoplasmic reticulum in eukaryotes[1][3]. However, RN7SL106P itself is a truncated, non-functional copy (pseudogene) of the 7SL RNA and is not expressed as a functional RNA or protein[4][5][6]. Pseudogenes like RN7SL106P arise from reverse transcription and genomic integration of RNA copies and do not encode active roles in cellular biology[4][5]. They are not considered receptors, enzymes, or viable drug targets.

Other names: RN7SL106P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 106, pseudogene (RN7SL106P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 106, pseudogene (RN7SL106P).

Explore the full profile